No account?
Sign
Fenghuang Wang Home phone Fenghuang Wang
heavy patrol boats gathered on the Diaoyu Islands China
additional anti-craft, set up to monitor base-band show in Japan over the Diaoyu Islands muscles, what Chinese penetration trick? Jobs: changing times urchin
full of his work back to the past of childhood, which grabs you the deepest secrets of my heart. Directed by Gordon Chan: Hong Kong painting Spring
impossible without culture; the money to put too high a tragedy; just north of Hong Kong director transition.
Font Size: T | T 0 participants 0 comments Print Forward
Chengzhi Life Technology Co., Ltd. intends to purchase
Bioenergy's D-ribose-related intangible item
asset evaluation report
assessment report by the word Beijing (2011), No. 001
(of a first book)
rating agencies Name: Beijing Jingwei Assets Appraisal Co., Ltd. Teco
report Date: August 23, 2011
Chengzhi Bioenergy Life Science and Technology Co., Ltd. intends to acquire the company's D-ribose-related intangible assets of the project evaluation report directory
asset evaluation report
directory
one, the client, and business units agreed to be assessed written agreement of the other assessment users profile .................... 3
(a) Principal - Chengzhi Life Technology Co., Ltd.. .................................................. ................. 3
(b) The assessment unit-BIOENERGY, INC. .............. .................................................. .... 4
(c) the engagement letter agreement and other assessment users ......................... ............................... 5
Second, the purpose of the evaluation ....... .................................................. .................................................. ............ 6
Third, the assessment of the object and scope of the assessment ....................... .................................................. .......................... 6
(a) assess the object ........... .................................................. ............................................... 6
(b) the scope of the assessment ........................................ .................................................. .................. 6
(c) the type of enterprise reporting intangible assets, the number of legal ownership status ......... ................................... 8
(d) outside the corporate returns asset type, number ............................................. ..................... 12
(e) refer to other agencies report .............. .................................................. .......................... 12
four value types and their definitions ......... .................................................. .......................................... 12
V. Valuation Date ............................................. .................................................. .................. 13
six assessment based on .................... .................................................. ............................................... 13
(a) act according to ........................................ .................................................. ................ 13
(b) the legal basis ..................... .................................................. ................................... 13
(c) criteria based on .. .................................................. .................................................. .... 14
(d) ownership basis ................................ .................................................. ........................ 14
(e) to take price based on ............ .................................................. ............................................ 14
seven assessment ............................................ .................................................. ....................... 15
eight, assessment procedures and conditions of the implementation process ........... .................................................. ............................ 19
(a) a clear assessment of their basic business matters ...... .................................................. .......................... 19
(b) signed engagement letter ......... .................................................. ................................... 19
(c) the preparation of the assessment program. .................................................. ............................................... 19
(d) on-site investigation ........................................ .................................................. ................ 20
(e) to collect assessment information .................... .................................................. ............................ 20
(f) assessment estimates ......... .................................................. ............................................... 20
(g) prepare and submit an assessment report ..................................... ................................................. 20
(eight) working papers archive ..................................... .................................................. ........... 20
nine, valuation assumptions ........................... .................................................. ........................................ 20
X. conclusions of the assessment ................................................ .................................................. ................... 21
XI particular matters described ................. .................................................. .......................................... 21
Beijing Jingwei Assets Appraisal Co., TECO's I
Chengzhi Bioenergy Life Science and Technology Co., Ltd's proposed acquisition of D-ribose-related intangible assets of the project evaluation report directory
for the assessment report use restrictions described .............................................. ............................................... 22
XIII assessment report on ....................................... .................................................. ........................ 23
Annex I, the relevant economic behavior file ........... .................................................. ......................... 40
Annex II, the client business license .......... .................................................. .............................. 41
Annex III to assess the object information related to the main proof of ownership .................................................. ........ 42
Annex IV, the client and related parties of the commitment letter ..................... ............................................. 43
Annex V, letter of commitment signed by CPV ..................................... ................................. 44
Annex VI, asset appraisal institution qualification. .................................................. ........................... 46
Annex VII, the rating agencies business license ........ .................................................. ............................ 47
Annex VIII,
tiffany, signed CPV qualification .... .................................................. ............ 48
Annex IX, it is important to take price basis ....................... .................................................. ..................... 49
Annex X, assess the engagement letter .............. .................................................. .......................... 50
Beijing Jingwei TECO Asset Appraisal Co., Ltd. II
Chengzhi Bioenergy Life Science and Technology Co., Ltd's proposed acquisition of D-ribose-related intangible assets of the project evaluation report directory
asset evaluation report Accessories catalog
important tips on is supporting information;
4, related parties, principal and letter of commitment;
5, letter of commitment signed by CPV;
6, assets rating agencies credentials;
7, rating agencies business license;
8, signed CPV credentials;
9, important to take price basis;
10, assessment of engagement letter.
Beijing Jingwei TECO Asset Appraisal Co., Ltd. III
Chengzhi Bioenergy Life Science and Technology Co., Ltd's proposed acquisition of D-ribose-related intangible assets of the project evaluation report states
Chengzhi Life Technology Co., Ltd. intends to purchase
Bioenergy's D-ribose-related intangible item
asset evaluation report states
assessment report by the Beijing words (2011), No. 001
First, we evaluate the implementation of the business assets, comply with relevant laws and regulations, and asset assessment criteria,
abide by the independent, objective and impartial manner; According to our data collected during practice, assessment Chan
above content is objective, and reasonable conclusions of the assessment to bear the corresponding legal responsibility.
Second, the assessment of the assets involved in the object list of declared and approved by the commissioning party to confirm their signature; the information
the authenticity, legality, integrity, appropriate use of assessment is the principal and the responsibility of the relevant parties.
Third, we report the assessment and evaluation of existing or expected object is not of interest; and related
parties, there is no existing or anticipated interest, the relevant parties there is no bias.
Fourth, we have assessed the report's assessment of the object and its assets involved in field investigations; we
has been involved in the assessment of objects and their legal ownership status of assets given the necessary attention, to assess the object and its
legal ownership of the assets involved in the identification data, and have found the issues truthfully disclosed,
and has been commissioned to draw parties and related party perfect property to meet the requirements of the assessment report issued.
Fifth, our assessment report issued by the analysis, judgments and conclusions of the assessment report by the assumptions and limits
conditions, the assessment should take full account of the user evaluation report contains that assumption, qualification,
special items described their impact on the assessment findings.
six CPV perform asset valuation business objective is to assess the value of the object to estimate
and published professional opinion, does not assume responsibility for decisions related to the parties. Conclusions of the assessment should not be considered to be
evaluation objects can be realized price guarantee.
seven, the user should be concerned about the assessment report with limited instructions.
Beijing Jingwei TECO Asset Appraisal Co., Ltd. Tel: (010) 68460389 Fax: (010) 68460389
Address: Haidian District, Beijing Zhongguancun South Street 34, Block C, Room 2409 (Code 100081) 1
Chengzhi Bioenergy Life Science and Technology Co., Ltd's proposed acquisition of D-ribose-related intangible assets of the project Executive Summary
Chengzhi proposed acquisition of Life Technologies Co., Ltd.
Bioenergy's D-ribose-related intangible item
asset evaluation report summary
assessment report by the word Beijing (2011), No. 001
Beijing Jingwei Assets Appraisal Co., Ltd. Teco Chengzhi Life Sciences Ltd has received the commission, registered capital
production appraisers under the requirements of asset evaluation criteria, in line with independent, objective and impartial manner, to follow the law
laws and regulations of the relevant provisions, in accordance with generally accepted asset valuation method, Chengzhi Life Technology Co., Ltd. intends to close
matters involving the purchase of assets of the company's D-Ribose Bioenergy related intangible assets in the June 30, 2011 of
investment value was evaluated and published professional advice. Now the situation and assess the results of asset evaluation summary
as follows:
one purpose of the evaluation: asset acquisition.
Second, assess and evaluate the scope of the object: The object of asset evaluation company's D-Ribose Bioenergy phase
off of intangible assets at the valuation date value of the investment; asset valuation range The purpose of the proposed acquisition involved
Bioenergy's D-ribose-related intangible assets.
three value types: investment value.
Fourth, the valuation date: June 30, 2011.
five assessment methods: income approach.
six conclusions of the assessment and its use is valid:
going to maintain the existing use under the premise of the valuation date as of June 30, 2011,
Commission assessment of intangible assets described in this assessment report its evaluation under the assumption that the value of RMB 110.67 million
million, capital of One billion RMB one thousand zero Lu Shi Qi million (rounded).
assessment using valid for one year from the valuation date June 30, 2011 through 2012 6
29.
we emphasize: The only conclusions of the assessment value of the assets acquired as a principal reference, and can not take
Beijing Jingwei TECO Asset Appraisal Co., Ltd. Tel : (010) 68460389 Fax: (010) 68460389
Address: Haidian District,
tiffany, Beijing Zhongguancun South Street 34, Block C, Room 2409 (PC 100081) 2
Chengzhi Life Technology Co., Ltd. intends to acquire
Bioenergy's D-ribose-related intangible item
assessment report by the word Beijing (2011), No. 001
Chengzhi Life Technology Co., Ltd.:
Beijing Jingwei Assets Appraisal Co., Ltd. Dong-won acceptance of your company's commission, in accordance with relevant laws, regulations and
asset evaluation criteria, asset valuation, assessment methods using the income method, according to the necessary assessment procedures,
Chengzhi Life Sciences Ltd Bioenergy to be acquisitions of companies involved in D-ribose-related intangible assets
project in 2011 June 30, the investment value of assessed work. Such as asset evaluation report now
following:
one, the client has been assessed units and engagement letter agreed to use other assessment
who Overview
(a) Principal - Chengzhi Life Technology Co., Ltd.
1, registration
Name: Chengzhi Life Technology Co., Ltd.
Address: Jiangxi Nanchang Economic and Technological Development Zone, No. 299 East Street, Yuping Tsinghua Science Park (Jiangxi) Hua Jiang
Building, 8th Floor
Registered Capital: 30,
tiffany,000 ten thousand yuan RMB
paid-up capital: 30,000 ten thousand yuan
Legal representative: Zhang Ximin
Ownership: limited liability company
2, the business scope
produce environmentally-friendly energy-saving products, biochemical products, fine chemicals, packaged foods; regulations prohibit,
Beijing Jingwei TECO Asset Appraisal Co., Ltd. Tel: ( 010) 68460389 Fax: (010) 68460389
Address: Haidian District, Beijing Zhongguancun South Street 34, Block C, Room 2409 (PC 100081) 3
not operate; should After approval, without approval may not operate; laws and regulations did not provide approval, self
selection operation project, to carry out business activities.
Chengzhi Chengzhigufen Life Technology Co., Ltd. is a wholly owned subsidiary.
(b) The assessment unit-BIOENERGY, INC.
1, registration
Bioenergy Inc. (Bioenergy) headquartered in Minnesota, USA 55304Ham Lake, NE,
Johnson Street, No. 13840, is a mission to improve the dietary health of integrated biotechnology company.
products in the application of D-ribose, is an international leader, with D-ribose nutrition and health care fields 21
entry application patents, including eight U.S. patents and certain items corresponding foreign patents. Core product
is a pentose, carbohydrates, ribose-oriented series to promote metabolism, enhance physical fitness, improve the immune system
health care products.
2, the financial position
three years before the baseline assessment of the assets and profit and loss position in the table below:
Consolidated Balance Sheets
Unit: USD
item 201020092008
current assets
cash and cash equivalents 27,898276,472177,057
receivable section 953,959676,827869790
inventory 610,485588,2492,460,878
other current assets 119,059153,172144,483
Total current assets 1,711,4011,694,7203,652,208
net fixed assets 145,582214,620226,385
other long-term assets 655,993471,671512,953
Total assets 2,512,9762,381,0114,391,546
liabilities and shareholders' equity (deficit)
current liabilities
a long-term debt due within one year and notes payable 2,314,4665,142,2992,056,547
line of credit 102,798130,718938,523
accounts payable 800, 5031,030,1401,976,773
accrued expenses 971,6961,539,440955,518
Beijing Jingwei TECO Asset Appraisal Co., Ltd. Tel: (010) 68460389 Fax: (010) 68460389
Address: Haidian District, Beijing Zhongguancun South Street 34, Block C, Room 2409 (PC 100081) 4
Total current liabilities 4,189, 4637,842,5975,927,361
notes payable and long-term liabilities net 743,1212,523,2505,300,164
bio-energy company shareholders' equity (deficit)
INC subsidiary -6,908,987-8,721,456804,866
minority interests 4,489,379736,620-7,640,845
liabilities and owners (or shareholders) equity $ 2,512,976 $ 2,381,011 $ 4,391,546
consolidated financial statements
ended September 30 201 020 092 008
revenue 11,964,3368,842,30311,370,482
operating costs 5,801,8404,252,9775,160,151
Gross profit 6,162,4964,589,3266,210,331
operating expenses 6,305,6165,764,3846,273,817
operating profit (loss) -143 ,120-1 ,175,058-63, 486
interest 5596962,295
interest -1,692,059-1,196,651-1,157, 561
other 14,97011,6797,834
Total net other expenses -1,676,530-1,184,276-1,147,432
total loss -1,819,650-1,819,650-1,210,918
income tax
Net (loss) -1,819,650-2, 359,334-1,210,918
subsidiary -163,190108,53046,293
bio-energy company losses -1,982,840-2,250,804 -1,164,625
Note: The data in the table are audited data.
3, the commissioning party and the assessment unit (or units of equity holding) the relationship between
the commissioning party and the assessment unit is the relationship between the acquirer of assets and asset sales-West relations .
(c) the engagement letter agreement and other assessment users
addition to commissioning parties themselves, engagement letter agreement and other assessment users, including Chengzhigufen Co., Ltd.
and state laws and regulations of the assessment report users.
Chengzhigufen Ltd Profile:
1, registration
Company Name: Chengzhigufen Co., Ltd.
legal residence (or premises): Jiangxi Nanchang Economic and Technological Development Zone, No. 299 East Street, Yuping
Beijing Jingwei TECO Asset Appraisal Co., Ltd. Tel: (010) 68460389 Fax: (010) 68460389
Address: Haidian District, Beijing Zhongguancun South Street 34, Block C, Room 2409 (PC 100081) 5
Registered Capital: 297,032,400 yuan
Company Type: Listed Companies
legal representative: David Long
2, scope of business
life sciences, bio-engineering, hospital investment management, Chinese and Western medicine, pharmaceutical intermediates , medical equipment, day
use and specialty chemicals, automotive parts, paper products and machinery and electronic product development, production and sales;
technology development, transfer, consulting services ; property management; own products and related technology import and export business.
Second, for evaluation purposes
Chengzhi Bioenergy Life Science and Technology Co., Ltd's proposed acquisition of D-ribose-related intangible assets, the need for
involved in the economic behavior D-Ribose Bioenergy's assessment of the value of intangible assets related to, this data
production evaluation purposes is fair to reflect the company's D-Ribose Bioenergy-related intangible assets at the valuation date of the vote
capital value, delivering value for the asset acquisition of reference. The economic activity has been Chengzhi Life Sciences
Co. board of directors for the first time the Board of Directors resolution ([2011] No. 001) approval.
Third, the assessment of the object and scope of the assessment
The delegate object and scope of the assessment and the assessment of economic activity related to the scope of the assessment and evaluation of the same object,
and did not After accounting firms.
(a) assess the object
object of this evaluation purposes for the assets involved in the acquisition of the company's D-Ribose Bioenergy-related intangible assets
produced in the assessment base Japan's investment value.
(b) assess the range of
scope of this evaluation purposes for the acquisition of the assets included in this assessment covered the range of Bioenergy Corporation
of D-ribose related intangible assets. Commission-related intangible assets as patents, a total of three groups, the first Games, estimate
of all patent rights, title and interest; 2 Games Organizing Committee estimates that people were entitled to the patent; 3 Group
Commission estimated that patent licensing fees exemptions, permanent and exclusive license. Committee estimate of specific patent assets as follows:
Beijing Jingwei TECO Asset Appraisal Co., Ltd. Tel: (010) 68460389 Fax: (010) 68460389
Address: Haidian District, Beijing Zhongguancun South Street, Room 2409, Block C, No. 34 (Code 100081) 6
> 6,534,480 to increase body energy formula
6,159,942 increase in body energy formula
6,511,964 symptoms of acute mountain way
6,525,027 applications ribose supplements to increase muscle mass and reduce body fat
6,429,198 increase in motor function of mammalian formula
U.S. Patent Registration No. corresponding to 6,159,942 of all foreign patents, set out as follows:
foreign registration number registration
CA 2334415 Canada
CN 101264093 China
EP 1087779 European Patent Convention (EPC)
EP 1745789 European Patent Convention (EPC)
JP 2002518321 Japan
JP 20100168394 Japan
NZ 508478 New Zealand
U.S. Patent No. 6,159,943 patent registration (using ribose to prevent cramps and muscle soreness) relative
corresponding foreign patents, are listed below:
foreign registration number registration
AU 783796 Australia
JP 2003516315 Japan
JP 2011093910 Japan
TECO
Beijing Jingwei Assets Appraisal Co., Ltd. Tel: (010) 68460389 Fax: (010) 68460389
Address: Haidian District, Beijing Zhongguancun South Street 34, Block C, Room 2409 (Code 100081) 7
CA 2383284 Canada
EP 1235581 European Patent Office
ZL00814276.9 China
GB 2352175 England
as follows:
foreign registration number registration
ZL01813522.6 China
EP 1313488B1 European Patent Office
JP 2004505056 Japan
6,218,366 threshold method to improve hypoxia
7,553,817 to improve cardiovascular function formulations and methods
(c) the type of corporate reporting of intangible assets , the number of legal ownership status
Commission estimated intangible asset type, quantity, legal ownership of the specific situation is as follows:
(1) U.S. Patent Registration No.: 6,159,942
patent name: used to increase body energy composition
patent types: invention patents
filing date: 1999-04-12
grant date: 2000-12-12
registered U.S. Patent No. 6,159,942 and related applications in other countries legal situation:
Beijing Jingwei Assets Appraisal Co., TECO Company Phone: (010) 68460389 Fax: (010) 68460389
Address: Zhongguancun South Street Haidian District, Beijing, No. 34, Block C, Room 2409 (PC 100081) 8
China-related applications and legal status: CN1264093 (unauthorized ,1999-6-17)
European Patent Office related to the application and legal status: EP1087779 (unauthorized ,1999-6-17)
European Patent Office related to the application and legal status: EP1745789 (unauthorized ,1999-6-17)
Japan-related applications and legal status: JP 2002518321 (reject 1999-2001 -6-17)
Japan-related applications and legal status: JP 2010168394 (unauthorized ,2010-04-08)
New Zealand-related applications and legal status: NZ508478 (authorized 2004-2006 -02-09)
related applications and legal status in Canada: CA2334415 (grant date ,2004-08-24)
U.S. Patent Abstract: The present invention discloses a precursor of adenosine triphosphate by oral administration as a food fortifier
used to increase the concentration of intracellular ATP due to consumption or physical activity for the treatment of disease or trauma caused by energy efficient
reduced. Pentose alone application, or mixing in dry food or in solution delivery. Preferred pentose is D-ribose,
alone application or with creatine, pyruvate, L-carnitine and / or combined application of vasodilator drugs. In addition, you can be
magnesium, electrolytes, fatty acids and hexose. The composition of this invention and the method is particularly conducive to low-energy-efficiency
energy demand under or mammals.
applications (U.S. patents claim 1): one for increased ischemic injury without the subject's health
human, dog or cat's energy level method including to humans, dogs or cats orally administering an effective amount
the pentose.
(2) U.S. Patent registration number: 6,534,480
patent name: used to increase body energy composition
patent types: invention Patents
filing date: 2000-12-18
grant date: 2003-03-18
U.S. Patent Abstract: The present invention discloses a precursor of adenosine triphosphate After oral administration as a food enhancer
used to increase the concentration of intracellular ATP due to consumption or physical activity for the treatment of disease or trauma caused by energy efficient
reduced. Pentose alone application, or mixing in dry food or in solution delivery. Preferred pentose is D-ribose,
alone application or with creatine, pyruvate, L-carnitine and / or combined application of vasodilator drugs. In addition, you can be
magnesium, electrolytes, fatty acids and hexose. The composition of this invention and the method is particularly conducive to low-energy-efficiency
Beijing Jingwei TECO Asset Appraisal Co., Ltd. Tel: (010) 68460389 Fax: (010) 68460389
Address : South Street, Haidian District, Beijing Room 2409, Block C, No. 34 (Code 100081) 9
energy demand under or mammals.
applications (U.S. patents claim 1): a way to improve health of mammalian skeletal muscle ATP levels
method, the method comprising orally administering to the mammal an effective amount of E sugar.
(3) U.S. Patent registration number: 6,159,943
patents Name: Use the ribosome to prevent muscle spasms and pain
patent types: invention patents
filing date: 1999-09-24
grant date: 2000-12-12
U.S. Patent No. 6,159,943 registered in other countries related application and legal situation:
China-related applications and legal status: ZL00814276.9 (authorized ,2006-3-29)
European Patent Office related to the application and legal status: EP1, 235 , 581 (authorization ,2006-04-05)
Japan-related applications and legal status: JP 2001524411 (rejected ,2000-09-22)
Japan-related applications and legal status: JP 2011093910 (unauthorized ,2010-12-03)
Australia legal status of the relevant applications and: AU783796 (authorized ,2006-03-23)
related applications and legal status in Canada: CA2383284 (grant date ,2011-03-15)
UK Patent Office-related applications and legal status: GBEP 2352175 (authorized ,2001-06-19)
U.S. Patent Abstract: ribose given before exercise to reduce or prevent exercise-induced muscle cramps and
pain. Taken before exercise, immediately after exercise ribose and ribose can be taken to further reduce or prevent exercise induced
made of muscle cramps and pain.
applications (U.S. patents claim 1): A mammalian skeletal muscle to prevent exercise-induced internal
muscle cramps and pain of the method, which includes pre-exercise described in mammals enough time to
to an effective amount of ribose, ribose in motion the process of making present in mammalian skeletal muscle as described in the steps.
(4) U.S. Patent registration number: 6,429,198
patent name: increased motor function of mammalian formula
patent types: invention patents
filing date: 2000-10-03
Beijing Jingwei TECO Asset Appraisal Co., Ltd. Tel: (010) 68460389 Fax: (010) 68460389
Address: Haidian District, Beijing Zhongguancun South Street 34, Block C, Room 2409 (PC 100081) 10
grant date: 2002-08-06
U.S. Patent Abstract: pentose mammals given, to increase exercise performance and reduce fatigue.
applications (U.S. patents claim 1): A method to increase sports performance, the method includes
the oral application of a certain amount of mammalian pentose, the amount of energy effectively increase the performance of the movement described in mammals.
(5) U.S. patent number: 6,525,027
patents Name: Application ribose supplements to increase muscle mass and reduce body fat
patent Type: patents
filing date: 2001-01-19
grant date: 2003-02-25
U.S. Patent Abstract: Compared to not give ribose weight-bearing exercises, weight-bearing exercise to give people the nuclear
sugar can increase muscle mass more quickly and reduce body fat.
applications (U.S. patents claim 1): A method, including weight-bearing exercise for people to
to the ribose, as described in people in order to reduce body fat.
(6) U.S. patent number: 6,511,964
Patent Title: Treatment of symptoms of acute mountain way
patent types: invention patent
filing date: 2001-03-29
grant date: 2003-01-28
U.S. Patent Abstract: hit high altitude maladjusted people through daily applied once to four times the nuclear
sugar can prevent or reduce symptoms of acute mountain sickness, high altitude experience from the application immediately after the start, and continue to
least 5 days.
applications (U.S. patents claim 1): one to prevent or reduce symptoms of acute mountain sickness feed
milk animals symptoms of acute mountain sickness method including mammals use enough to prevent or mitigate the
effective amount of the above symptoms of ribose.
(7) U.S. Registration No. 6,218,366
patent name: increased hypoxia threshold method
patent types: invention patent
Beijing Jingwei TECO Asset Appraisal Co., Ltd. Tel: (010) 68460389 Fax: (010) 68460389
Address: Haidian District, Beijing Zhongguancun South Street 34, Block C, Room 2409 (PC 100081) 11
Application Date: 1999-9-24
grant date: 2001-04-17
U.S. Patent Abstract: A treatment methods, including application to the mammal an effective amount of ribose to increase the
mammalian tolerance to hypoxia, which ribose in hypoxic event found in the mammalian tissues.
(8) U.S. Registration No. 7,553,817
patent name: to improve cardiovascular function formulations and methods
patent types: invention patents
filing date: 2003-10-23
grant date: 2009-06-30
registered U.S. Patent No. 7,553,817 related applications in other countries and legal situation:
China-related applications and legal status: ZL01813522.6 (authorized ,2007-2-14)
European Patent Office related to the application and legal status: EP1313488 (authorization, 2006-12-13)
Japan-related applications and legal status: JP 2004505056T (unauthorized ,2001-07-27)
U.S. Patent Abstract: This invention relates to additional risk for cardiovascular or peripheral vascular disease patients or easily
in patients suffering from these diseases, the composition of the diet. Ribose alone or with vasodilator drugs, nutrients and vitamin
combination of elements of one or more of its administration. Preferred vitamins include vitamin C, B6, B12 and folic acid. Preferred
nutrients, including glutamine and glucose.
applications (U.S. patents claim 1): the main claims: one for the improvement of cardiovascular function
energy, including 1-4 times a day to patients administration of 2-10 grams of D-ribose.
(d) of assets outside the business returns the type, quantity
no.
(e) refer to other agencies report
no.
four value types and their definitions
based assessment purposes, market conditions, assessment of the object's own conditions and other factors, taking into account the value of the type
assessment assumptions correlations to determine the value of this type of asset valuation: Investment value.
Beijing Jingwei TECO Asset Appraisal Co., Ltd. Tel: (010) 68460389 Fax: (010) 68460389
Address: Haidian District, Beijing Zhongguancun South Street 34, Block C, Room 2409
Zl00814276.9
Hybrid Mode
